Research Interests:

• Muscle-bone crosstalk during exercise, neuromuscular diseases, and aging.   
• Cellular and molecular mechanisms of musculoskeletal injuries and regeneration.

Ongoing Projects:

• Targeting muscle and bone comorbidities by replenishing nitric oxide (NO) in dystrophic muscle via inorganic nitrite.  
• Role of FGF21 in the pathogenesis of Duchenne Muscular Dystrophy.  
• Role of vascular endothelial cells in diabetic bone healing.

Funding support:

1. Role of FGF21 in DMD

• NIH/NIAMS R01AR083398
• Hongshuai Li (PI), Ling Wang (Co-I)
• Aug 7, 2024 - Jun 30, 2029

  2. Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy 

• NIH/NIAMS R01 AR076357
• Hongshuai Li (PI), Ling Wang (Co-I)
• Sep 15, 2020 - Aug 31, 2026

  3. Omics, Mice and Men: Development of Precision Transfusion Medicine 

• NIH/NHLBI R01 HL098032 Mark T. Gladwin (Primary PI at University of Maryland)
• Ling Wang (Sub-award PI)
• Sep 15, 2023 - Jul 31, 2028